Keith Rushlow

 Experienced Academic and Commercial R&D Scientist: Conducted and managed academic and industry research programs resulting in 29 published abstracts, 15 invited reviews, 40 peer-reviewed articles in leading scientific journals, and 22 issued U.S. patents covering basic molecular biology, virology, immunology, infectious disease, vaccines, diagnostics, and nutrition with commercial relevance to animal and human healthcare applications
 Diverse Professional Experience: Applied and strategic R&D, science education and communication, and business-related experience in diverse research environments including universities, government and private research institutes, biotechnology start-up companies, and a global diversified human healthcare company. Expert analysis and effective educator/communicator of complex scientific concepts and principles to non-technical personnel. Consultant to biotechnology/pharmaceutical companies, market research organizations, and venture capital investment groups on a broad range of scientific, biotechnology and health-related subjects
 Science/Technology and Opportunity Assessment Specialist: Effective leader and coordinator of multidisciplinary project teams involving Business Development, Medical & Regulatory Affairs, Patent/Legal, Manufacturing, and Commercial/Marketing for the purpose of assessing the potential market value of emerging and novel healthcare technologies, and determining their probability of technical and commercial success. Delivers risk-adjusted recommendations on licensing of patents/IP, pre-clinical/clinical stage technologies, acquisition of finished products, and investment in companies important to the long-term strategic interest of the business.